Barzolvolimab (Synonyms: CDX 0159) |
| Catalog No.GC68727 |
Barzolvolimab (CDX 0159) es un anticuerpo monoclonal humanizado IgG1 contra KIT. Barzolvolimab inhibe de manera específica y efectiva la activación de KIT. Barzolvolimab puede reducir los mastocitos cutáneos y la actividad de la enfermedad en el urticaria crónica inducida.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2438203-51-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Barzolvolimab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Barzolvolimab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *